Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Witty

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Progress in Medicinal Chemistry|February 9, 2016
PrefaceGeoff Lawton, David Witty
Progress in Medicinal Chemistry|January 15, 2014
PrefaceGeoff Lawton, David Witty
Progress in Medicinal Chemistry|March 3, 2015
PrefaceGeoff Lawton, David Witty
Progress in Medicinal Chemistry|May 6, 2011
Advances in the design of 5-HT6 receptor ligands with therapeutic potentialDavid Witty, Mahmood Ahmed, Tsu Tshen Chuang
The Journal of Organic Chemistry|April 27, 2002
Unified route to the palmarumycin and preussomerin natural products. Enantioselective synthesis of (-)-preussomerin GAnthony G M Barrett, Frank Blaney, Andrew D Campbell, et al.
Journal for Immunotherapy of Cancer|November 2, 2021
BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonismKristen Hurov, Johanna Lahdenranta, Punit Upadhyaya, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Potent oxadiazole CGRP receptor antagonists for the potential treatment of migrainePaula L Nichols, Jonathan Brand, Michael Briggs, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Progress in Medicinal Chemistry|February 9, 2016
PrefaceGeoff Lawton, David Witty
Progress in Medicinal Chemistry|January 15, 2014
PrefaceGeoff Lawton, David Witty
Progress in Medicinal Chemistry|March 3, 2015
PrefaceGeoff Lawton, David Witty
Progress in Medicinal Chemistry|May 6, 2011
Advances in the design of 5-HT6 receptor ligands with therapeutic potentialDavid Witty, Mahmood Ahmed, Tsu Tshen Chuang
The Journal of Organic Chemistry|April 27, 2002
Unified route to the palmarumycin and preussomerin natural products. Enantioselective synthesis of (-)-preussomerin GAnthony G M Barrett, Frank Blaney, Andrew D Campbell, et al.
Journal for Immunotherapy of Cancer|November 2, 2021
BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonismKristen Hurov, Johanna Lahdenranta, Punit Upadhyaya, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Potent oxadiazole CGRP receptor antagonists for the potential treatment of migrainePaula L Nichols, Jonathan Brand, Michael Briggs, et al.
Pageof 1